Analysts warn the levies could disrupt global drug supply chains, push up medicine prices for Americans and force Indian drugmakers to rethink their manufacturing strategies.
Asia
Analysts warn the levies could disrupt global drug supply chains, push up medicine prices for Americans and force Indian drugmakers to rethink their manufacturing strategies.
Pharmacists sort and sell medicines to customers inside a pharmacy in Kolkata, India, Feb 2, 2026. (Photo: Reuters/Sahiba Chawdhary)
New: You can now listen to articles.
This audio is generated by an AI tool.
Trump's generic drugs tariff threatens Indian pharma's top market
US tariffs could raise drug prices, squeeze Indian generics
Pharma companies in a flux over Trump's 200% tariff move on generics
Trump's 200% generic drug tariff threat puts $9.7 billion Indian pharma exports at risk; industry says reshoring not practical
Indian pharma firms may yet survive Trump's 200% tariff bombshell
Pharma stocks slide as Trump's 100% generic drug tariff plan spooks investors
Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm
Stocks fall, pharma firms fret. Indian drug manufacturers sweat over Trump's 100% levy on generics
Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?
0, 100, 200: How Trump's latest generic medicines tariffs could affect India
NEW DELHI: India's $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that…
India's $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that generic…
US President Trump's proposed tariffs on imported generic drugs will not immediately affect Indian drugmakers. Indian companies…
